| Style | Citing Format |
|---|---|
| MLA | Abtahi Naeini B, et al.. "Acrodermatitis Dysmetabolica As a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases." Health Science Reports, vol. 9, no. 10, 2026, pp. -. |
| APA | Abtahi Naeini B, Heidari Beni M, Rostampour N, Davoudi N, Seyedyousefi S (2026). Acrodermatitis Dysmetabolica As a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases. Health Science Reports, 9(10), -. |
| Chicago | Abtahi Naeini B, Heidari Beni M, Rostampour N, Davoudi N, Seyedyousefi S. "Acrodermatitis Dysmetabolica As a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases." Health Science Reports 9, no. 10 (2026): -. |
| Harvard | Abtahi Naeini B et al. (2026) 'Acrodermatitis Dysmetabolica As a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases', Health Science Reports, 9(10), pp. -. |
| Vancouver | Abtahi Naeini B, Heidari Beni M, Rostampour N, Davoudi N, Seyedyousefi S. Acrodermatitis Dysmetabolica As a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases. Health Science Reports. 2026;9(10):-. |
| BibTex | @article{ author = {Abtahi Naeini B and Heidari Beni M and Rostampour N and Davoudi N and Seyedyousefi S}, title = {Acrodermatitis Dysmetabolica As a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases}, journal = {Health Science Reports}, volume = {9}, number = {10}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Abtahi Naeini B AU - Heidari Beni M AU - Rostampour N AU - Davoudi N AU - Seyedyousefi S TI - Acrodermatitis Dysmetabolica As a Cutaneous Manifestation of Isoleucine Deficiency in Maple Syrup Urine Disease: A Systematic Review of Reported Cases JO - Health Science Reports VL - 9 IS - 10 SP - EP - PY - 2026 ER - |